Puhl, A. C., Vignaux, P. A., Minerali, E., Klein, J. J., Havener, T. M., Anderson, E., … Ekins, S. (2021). Repurposing drugs for CLN1 Batten disease: An integrative drug discovery approach. Molecular Genetics and Metabolism, 132(2), S88–S89. https://doi.org/10.1016/j.ymgme.2020.12.212

Puhl, Ana C., Patricia A. Vignaux, Eni Minerali, Jennifer J. Klein, Tammy M. Havener, Edward Anderson, Anthony J. Hickey, and Sean Ekins. “Repurposing drugs for CLN1 Batten disease: An integrative drug discovery approach.” Molecular Genetics and Metabolism 132, no. 2 (February 2021): S88–89. https://doi.org/10.1016/j.ymgme.2020.12.212.

Puhl AC, Vignaux PA, Minerali E, Klein JJ, Havener TM, Anderson E, et al. Repurposing drugs for CLN1 Batten disease: An integrative drug discovery approach. Molecular Genetics and Metabolism. 2021 Feb;132(2):S88–9.

Puhl, Ana C., et al. “Repurposing drugs for CLN1 Batten disease: An integrative drug discovery approach.” Molecular Genetics and Metabolism, vol. 132, no. 2, Elsevier BV, Feb. 2021, pp. S88–89. Crossref, doi:10.1016/j.ymgme.2020.12.212.

Puhl AC, Vignaux PA, Minerali E, Klein JJ, Havener TM, Anderson E, Hickey AJ, Ekins S. Repurposing drugs for CLN1 Batten disease: An integrative drug discovery approach. Molecular Genetics and Metabolism. Elsevier BV; 2021 Feb;132(2):S88–S89.